We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$10.6B
AUM Growth
-$1.52B
Cap. Flow
+$47.1M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.51%
Holding
395
New
8
Increased
194
Reduced
112
Closed
28

Top Sells

Rank Stock Value
1
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$66.2M
2
MTB icon
M&T Bank
MTB
+$43.8M
3
BKR icon
Baker Hughes
BKR
+$38.3M
4
ORCL icon
Oracle
ORCL
+$36.5M
5
CDK
CDK Global, Inc.
CDK
+$35.6M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 17.05%
3 Financials 15.67%
4 Industrials 13.84%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
151
Acuity Brands
AYI
$10.3B
$24.2M 0.23%
157,383
+2,155
+1% +$365K
EVR icon
152
Evercore
EVR
$13.2B
$24.2M 0.23%
258,002
+4,391
+2% +$468K
BRK.B icon
153
Berkshire Hathaway Class B
BRK.B
$1.11T
$23.9M 0.23%
87,560
-731
-0.8% -$229K
FWRD icon
154
Forward Air
FWRD
$467M
$23.7M 0.22%
257,441
+1,683
+0.7% +$156K
CENTA icon
155
Central Garden & Pet Co Class A
CENTA
$2.44B
$23.6M 0.22%
737,664
+12,400
+2% +$408K
RHI icon
156
Robert Half
RHI
$4.04B
$22.9M 0.22%
305,645
+6,247
+2% +$592K
HELE icon
157
Helen of Troy
HELE
$672M
$22.7M 0.21%
139,531
+2,023
+1% +$381K
TFX icon
158
Teleflex
TFX
$5.94B
$22.4M 0.21%
91,001
+70,681
+348% +$20.6M
ENSG icon
159
The Ensign Group
ENSG
$10.7B
$21.7M 0.21%
295,482
+3,088
+1% +$246K
CRL icon
160
Charles River Laboratories
CRL
$11.6B
$21.6M 0.2%
101,113
+2,211
+2% +$540K
DLB icon
161
Dolby
DLB
$4.97B
$21.6M 0.2%
301,163
+143,229
+91% +$10.8M
CL icon
162
Colgate-Palmolive
CL
$74.2B
$21.1M 0.2%
263,413
+4,580
+2% +$358K
TTC icon
163
Toro Company
TTC
$9.08B
$21M 0.2%
277,040
+6,495
+2% +$527K
CVX icon
164
Chevron
CVX
$374B
$20.8M 0.2%
143,813
+28,501
+25% +$4.71M
CPK icon
165
Chesapeake Utilities
CPK
$3.31B
$20.5M 0.19%
158,015
+286
+0.2% +$37.3K
SSTK icon
166
Shutterstock
SSTK
$220M
$20.2M 0.19%
352,698
+1,184
+0.3% +$79.3K
NSP icon
167
Insperity
NSP
$2.01B
$20.2M 0.19%
201,959
+1,690
+0.8% +$167K
UTL icon
168
Unitil
UTL
$1.01B
$20M 0.19%
340,757
+3,324
+1% +$179K
META icon
169
Meta Platforms (Facebook)
META
$1.51T
$19.2M 0.18%
118,833
-35,100
-23% -$6.77M
AMAT icon
170
Applied Materials
AMAT
$378B
$19.1M 0.18%
209,959
+14,664
+8% +$1.61M
PYPL icon
171
PayPal
PYPL
$51.4B
$19.1M 0.18%
272,892
-12,027
-4% -$1.04M
FIX icon
172
Comfort Systems
FIX
$57.2B
$18.8M 0.18%
226,481
+1,284
+0.6% +$110K
MNRO icon
173
Monro
MNRO
$537M
$18.2M 0.17%
424,087
+131,596
+45% +$5.88M
CUBE icon
174
CubeSmart
CUBE
$9.62B
$18.2M 0.17%
425,469
+8,425
+2% +$388K
BOH icon
175
Bank of Hawaii
BOH
$3.17B
$17.9M 0.17%
240,302
+2,379
+1% +$183K

Similar funds

Boston Trust Walden's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Trust Walden held 395 positions worth $10.6B, down 13% from $12.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q2 2022 filing shows 8 new, 194 increased, 112 reduced and 28 closed positions. Its largest new stake was Core Laboratories: 1,993,528 shares worth $39.5M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $66.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q2 2022 buy was Core Laboratories: 1,993,528 shares worth $39.5M.
  • Boston Trust Walden added most to Americold in Q2 2022, an estimated $32.5M increase.
  • Boston Trust Walden's biggest Q2 2022 reduction was M&T Bank, cutting an estimated $43.8M.
  • Boston Trust Walden fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $66.2M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $10.6B portfolio in Q2 2022.
  • Boston Trust Walden opened 8 new positions and closed 28 in Q2 2022.
  • Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $10.6B.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.